Enzyme Inhibition

Enzymes: Key Concepts and Takeaways

  • Understanding Enzyme Inhibition

    • Need to know different types of enzyme inhibition:

    • Competitive Inhibition

    • Non-competitive Inhibition

    • Uncompetitive Inhibition

    • Feedback Inhibition

    • Impact on Michaelis-Menten kinetics:

    • Understanding how each type of inhibition affects the parameters $Km$ (Michaelis constant) and $V{max}$ (maximum velocity).

    • Must be able to distinguish different types of inhibition using Lineweaver-Burk Plots.

    • Allostery:

    • Understanding what allostery is, along with its implications for allosteric inhibition and activation of enzymes.

    • Impact of allostery on Michaelis-Menten equation leading to the Hill equation:

    • Cooperativity scenarios:

      • $n < 1$ (negative cooperativity)

      • $n > 1$ (positive cooperativity)

      • $n = 1$ (no cooperativity)

    • For reference, material is covered in the online book on page 355.

Enzyme Inhibition Overview

  • Common Drug Targets

    • Many drugs function as enzyme inhibitors. Here are a few examples:

    • Statins:

      • Drug Examples: Atorvastatin, Simvastatin

      • Target Enzyme: HMG-CoA reductase

      • Therapeutic Use: Decrease plasma cholesterol levels (Antihyperlipidemic agents).

    • Allopurinol:

      • Target Enzyme: Xanthine oxidase

      • Therapeutic Use: Gout treatment.

    • Methotrexate:

      • Target Enzyme: Dihydrofolate reductase

      • Therapeutic Use: Cancer chemotherapy.

    • Captopril & Enalapril:

      • Target Enzyme: Angiotensin-converting enzyme

      • Therapeutic Use: High blood pressure management.

    • Dicoumarol:

      • Target Enzyme: Vitamin K epoxide reductase

      • Therapeutic Use: Anticoagulant.

Types of Enzyme Inhibition

  • Competitive Inhibition

    • Definition: Competitive inhibitors compete with the substrate for the active site of the enzyme, forming an enzyme-substrate complex.

    • Characteristics:

    • Typically structurally similar to the normal substrate, allowing competition for the active site.

    • Inhibition occurs because the enzyme can bind either the substrate or the inhibitor, but not both simultaneously.

    • Competitive inhibitor binds reversibly to the active site.

    • High substrate concentration can overcome the competitive inhibition, as it will outcompete the inhibitor for binding.

    • Applications: Many drugs act as competitive inhibitors due to their structural mimicry of a target enzyme's substrate.

  • Non-Competitive Inhibition

    • Definition: Non-competitive inhibitors bind to either the enzyme or the enzyme-substrate complex at a different site than the active site, reducing enzyme activity.

    • Characteristics:

    • Binding is reversible and causes a change in the enzyme's three-dimensional structure.

    • Since binding can occur with substrate and or the enzyme-substrate complex, its effects cannot be overcome by increasing substrate concentration.

    • Results in a decrease in $V{max}$ but does not affect $Km$ (Michaelis constant).

    • Example: The action of pepstatin on the enzyme renin is a classic example of non-competitive inhibition.

  • Uncompetitive Inhibition

    • Definition: Uncompetitive inhibitors bind to the enzyme only after the substrate has bound, affecting the enzyme-substrate complex.

    • Characteristics:

    • Inhibition occurs after substrate binding, leading to the substrate remaining associated with the enzyme.

    • The inhibitor decreases both substrate affinity (lowering $Km$) and $V{max}$.

    • Key Point: The effect of uncompetitive inhibition cannot be overcome by adding excess substrate.

Graphical Analysis of Enzyme Inhibition

  • Lineweaver-Burk Plot Analysis

    • Utilized to analyze the effects of enzyme inhibitors on kinetic parameters.

    • Impact of various inhibitors on Lineweaver-Burk Plots:

    • Competitive Inhibition:

      • $V_{max}$ is unchanged.

      • $K_m$ is increased, leading to lines intersecting on the Y-axis.

    • Non-competitive Inhibition:

      • $V_{max}$ is decreased.

      • $K_m$ is unchanged, leading to lines intersecting on the X-axis.

    • Uncompetitive Inhibition:

      • Both $V{max}$ and $Km$ decrease, resulting in two parallel lines.

Feedback Inhibition

  • Mechanism: Pathways are inhibited by their end products. Feedback inhibition helps in regulating metabolic pathways.

    • General Scheme:

    • Pathway consists of multiple enzymes converting an initial substrate (e.g., threonine) through intermediates.

    • Example: As levels of isoleucine rise, it binds to an allosteric site on enzyme 1, inhibiting its activity.

Allostery and Hill Coefficient

  • Allosteric Modulation

    • Allostery refers to the regulation of an enzyme's activity through the binding of molecules at sites other than the active site.

    • Two forms of allostery:

      • Allosteric Activation: Enhances enzyme activity.

      • Allosteric Inhibition: Reduces enzyme activity.

  • Hill Coefficient Quantification

    • Cooperativity (n):

      • $n = 1$: No cooperativity

      • $n > 1$: Positive cooperativity

      • $n < 1$: Negative cooperativity

    • The Hill equation is used to quantify the relationship and is expressed as:
      heta=[L]nKd+[L]nheta = \frac{[L]^{n}}{K_d + [L]^{n}}

    • Implications for Michaelis-Menten behavior under different conditions of cooperativity.

  • Graphical representation of the Hill equation shows changes in fraction bound based on cooperative binding effects across varying substrate concentrations, providing insights into the dynamics of enzyme activity.